[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100540170":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":21,"locations":27,"responsibleParty":44,"collaborators":10,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":10,"eligibilityCriteria":52,"healthyVolunteers":53,"sex":54,"minAge":55,"maxAge":10,"enrollmentInfo":56,"targetDuration":10,"studyType":59,"phases":10,"briefSummary":60,"conditions":61,"keywords":10,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Texas Woman's University","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Cancer treatment induced peripheral neuropathy",null,"Individuals with a history of non CNS cancer with cancer treatment induced peripheral neuropathy symptoms.",{"label":13,"type":10,"description":14,"interventionNames":10},"Control group","Age and gender matched individuals without peripheral neuropathy symptoms.",[16,19],{"name":17,"affiliation":5,"role":18},"Priya Karakkattil, PhD","PRINCIPAL_INVESTIGATOR",{"name":20,"affiliation":5,"role":18},"Asha Vas, PhD",[22],{"name":23,"role":24,"phone":25,"phoneExt":10,"email":26},"Priya Karakkattil","CONTACT","12148625624","Pkarakkattil@twu.edu",[28],{"facility":5,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"RECRUITING","Dallas","Texas","75235","United States","US",{"type":36,"coordinates":37},"Point",[38,39],-96.80667,32.78306,{"lat":39,"lon":38},[42],{"name":17,"role":24,"phone":43,"phoneExt":10,"email":26},"214-689-7726",{"type":18,"investigatorFullName":23,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Assistant Professor","100540170","fall-risk-and-quality-of-life-in-individuals-with-cancer-treatment-related-peripheral-neuropathy-100540170",false,"NCT06313359","Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy.","Fall Risk and Quality of Life: Influence of Dual Task Performance, Cognition, and Sensorimotor Variables in Individuals With Cancer Treatment Related Peripheral Neuropathy.","Inclusion Criteria:\n\nExperimental group\n\n* Individuals 18 years and older\n* diagnosed with non- CNS cancer who underwent treatment and presents with peripheral neuropathy symptoms.\n\nControl group\n\n* age (+\u002F- one year) and gender matched individuals\n* no diagnosed peripheral neuropathy\n* No diagnosed cognitive symptoms.\n\nExclusion Criteria:\n\n* Unable to follow two step commands.\n* Unable to ambulate x 50 feet independently without use of an assistive device.\n* Unable to use a phone to send text messages.\n* Diagnosis of diabetic peripheral neuropathy\n* Diagnosis of CNS cancer.\n* Unable to speak\u002Funderstand English",true,"ALL","18 Years",{"count":57,"type":58},40,"ESTIMATED","OBSERVATIONAL","The purpose of this research is to examine the impact of peripheral neuropathy on fall risk and quality of life in people who had cancer and neuropathy from cancer treatments. The investigators are interested to find out if the participant have any difficulty with thinking, feeling, balancing, or moving around that will contribute to risk for falls or quality of life. Investigators are also interested to see if the participants have any difficulty with doing two activities at the same time, such as walking and texting.",[62],"Peripheral Neuropathy Due to Chemotherapy","2025-09-02",{"date":65,"type":66},"2025-09-03","ACTUAL",{"date":68,"type":66},"2024-03-30",{"date":70,"type":58},"2026-06-30",{"name":5,"class":6},1]